Aleve and Sublimaze drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aleve (naproxen sodium) and Sublimaze (fentanyl citrate). Common drug interactions include disability among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Aleve and Sublimaze. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Aleve?
Aleve has active ingredients of naproxen sodium. It is often used in pain. eHealthMe is studying from 70,279 Aleve users. Check the latest studies of Aleve.
What is Sublimaze?
Sublimaze has active ingredients of fentanyl citrate. eHealthMe is studying from 560 Sublimaze users. Check the latest studies of Sublimaze.
15 people who take Aleve and Sublimaze together, and have interactions are studied.

What are the common drug interactions of Aleve and Sublimaze, by gender? *:
female:
- Disability
- Dizziness
- Fall
- Hyperglycaemia (high blood sugar)
- Oral disorder (mouth disease)
- Adnexa uteri mass (ovarian cysts)
- Anaemia (lack of blood)
- Arthralgia (joint pain)
- Balance disorder
- Contusion (a type of hematoma of tissue in which capillaries)
male:
- Anxiety
- Renal failure (kidney dysfunction)
- Alveolitis allergic (inflammation of the alveoli within the lung caused by hypersensitivity to inhaled organic dusts)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Appetite disorder (abnormal eating habits)
- Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
- Arthralgia (joint pain)
- Atrophic vulvovaginitis (inflammation of the vulva)
- Back pain
What are the common drug interactions of Aleve and Sublimaze, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anxiety
- Chronic kidney disease
- Emotional distress
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Mobility decreased (ability to move is reduced)
- Renal cyst (kidney cyst)
- Renal failure (kidney dysfunction)
- Renal tubular necrosis (death of kidney tubules)
- Benign intracranial hypertension (benign intracranial hypertension (bih) is a headache syndrome)
- Csf pressure increased
40-49:
n/a
50-59:
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Necrosis (the death of body tissue)
- Neoplasm malignant (cancer tumour)
- Oral disorder (mouth disease)
- Osteitis (a general term for inflammation of bone)
- Osteomyelitis (infection of bone)
- Osteomyelitis chronic (long lasting infection of bone marrow)
- Osteonecrosis of jaw (death of bone of jaw)
- Osteopenia (a condition where bone mineral density is lower than normal)
60+:
- Abdominal pain
- Adnexa uteri mass (ovarian cysts)
- Depression
- Disability
- Dizziness
- Ear infection
- Excoriation (to tear or wear off the skin of)
- Fall
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Hyperglycaemia (high blood sugar)
What are the existing conditions these people have? *
- Hiv Infection: 3 people, 20.00%
- Hepatitis B: 3 people, 20.00%
- Lung Cancer - Non-Small Cell (lung cancer): 2 people, 13.33%
- Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 2 people, 13.33%
- High Blood Cholesterol: 2 people, 13.33%
- Multiple Allergies (allergy to multiple agents): 1 person, 6.67%
- Multi-Vitamin Deficiency (lack of vitamins): 1 person, 6.67%
- Infection: 1 person, 6.67%
- Headache (pain in head): 1 person, 6.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Aleve and Sublimaze?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aleve and Sublimaze:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aleve:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sublimaze:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aleve and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sublimaze and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on naproxen sodium and fentanyl citrate (the active ingredients of Aleve and Sublimaze, respectively), and Aleve and Sublimaze (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Constipation and drugs of ingredients of alpha - lipoic acid - 3 seconds ago
- Could Marijuana cause Gun Shot Wound? - 4 seconds ago
- Could Potassium Chloride cause Urinary Tract Disorder? - 14 seconds ago
- Stress And Anxiety in Epitol, how severe and when it was recovered? - 26 seconds ago
- Kidney Infection (Pyelonephritis) and drugs of ingredients of hydralazine hydrochloride; hydrochlorothiazide - 28 seconds ago
- Drug interactions of Vitamin B12 and Tagamet - 32 seconds ago
- Cymbalta and Weakness for Men aged 20-29 - 43 seconds ago
- Cymbalta and Asthenia for Men aged 20-29 - 43 seconds ago
- Cymbalta and Muscle Fatigue for Men aged 20-29 - 43 seconds ago
- Cymbalta and Muscular Weakness for Men aged 20-29 - 43 seconds ago